Immunocore Holdings Management

Management Kriterienprüfungen 2/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Bahija Jallal

Geschäftsführender

US$11.7m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts6.3%
Amtszeit als Geschäftsführer5.4yrs
Eigentum des Geschäftsführersn/a
Durchschnittliche Amtszeit des Managements2.4yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder4.8yrs

Jüngste Management Updates

Recent updates

Is Immunocore Holdings (NASDAQ:IMCR) Using Debt Sensibly?

May 11
Is Immunocore Holdings (NASDAQ:IMCR) Using Debt Sensibly?

Immunocore Holdings plc (NASDAQ:IMCR) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

May 11
Immunocore Holdings plc (NASDAQ:IMCR) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Are Investors Undervaluing Immunocore Holdings plc (NASDAQ:IMCR) By 25%?

Apr 05
Are Investors Undervaluing Immunocore Holdings plc (NASDAQ:IMCR) By 25%?

Here's Why Immunocore Holdings (NASDAQ:IMCR) Can Manage Its Debt Despite Losing Money

Jan 22
Here's Why Immunocore Holdings (NASDAQ:IMCR) Can Manage Its Debt Despite Losing Money

Immunocore Holdings: Vulnerable To Profit Taking After Big Rally

Jan 21

Revenues Not Telling The Story For Immunocore Holdings plc (NASDAQ:IMCR) After Shares Rise 37%

Dec 18
Revenues Not Telling The Story For Immunocore Holdings plc (NASDAQ:IMCR) After Shares Rise 37%

Some Confidence Is Lacking In Immunocore Holdings plc's (NASDAQ:IMCR) P/S

May 08
Some Confidence Is Lacking In Immunocore Holdings plc's (NASDAQ:IMCR) P/S

Forecast: Analysts Think Immunocore Holdings plc's (NASDAQ:IMCR) Business Prospects Have Improved Drastically

Nov 16
Forecast: Analysts Think Immunocore Holdings plc's (NASDAQ:IMCR) Business Prospects Have Improved Drastically

Immunocore: Attractive Commercial-Stage Biopharma

Oct 05

Need To Know: Analysts Are Much More Bullish On Immunocore Holdings plc (NASDAQ:IMCR)

Aug 12
Need To Know: Analysts Are Much More Bullish On Immunocore Holdings plc (NASDAQ:IMCR)

Immunocore GAAP EPS of -$0.17, revenue of $38.92M

Aug 10

Immunocore to raise $140M in private placement financing

Jul 18

Analysts Are Updating Their Immunocore Holdings plc (NASDAQ:IMCR) Estimates After Its Second-Quarter Results

Aug 15
Analysts Are Updating Their Immunocore Holdings plc (NASDAQ:IMCR) Estimates After Its Second-Quarter Results

Industry Analysts Just Upgraded Their Immunocore Holdings plc (NASDAQ:IMCR) Revenue Forecasts By 12%

May 20
Industry Analysts Just Upgraded Their Immunocore Holdings plc (NASDAQ:IMCR) Revenue Forecasts By 12%

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Bahija Jallal im Vergleich zu den Einnahmen von Immunocore Holdings verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Mar 31 2024n/an/a

-US$60m

Dec 31 2023US$12mUS$735k

-US$55m

Sep 30 2023n/an/a

-US$66m

Jun 30 2023n/an/a

-US$63m

Mar 31 2023n/an/a

-US$52m

Dec 31 2022US$1mUS$700k

-US$53m

Sep 30 2022n/an/a

-US$62m

Jun 30 2022n/an/a

-US$112m

Mar 31 2022n/an/a

-US$156m

Dec 31 2021US$35mUS$700k

-US$180m

Sep 30 2021n/an/a

-US$150m

Jun 30 2021n/an/a

-US$139m

Mar 31 2021n/an/a

-US$116m

Dec 31 2020US$1mn/a

-US$101m

Vergütung im Vergleich zum Markt: BahijaDie Gesamtvergütung ($USD11.68M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD5.67M).

Entschädigung vs. Einkommen: BahijaDie Bezüge der Mitarbeiter sind gestiegen, während das Unternehmen unrentabel ist.


Geschäftsführer

Bahija Jallal (63 yo)

5.4yrs

Amtszeit

US$11,678,834

Vergütung

Dr. Bahija Jallal, Ph.D. serves as Director of Outpace Bio, Inc. from March 2023. She serves as Chief Executive Officer and Director of Immunocore Holdings plc (formerly known as Immunocore Holdings Limite...


Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Bahija Jallal
CEO & Executive Director5.4yrsUS$11.68mkeine Daten
Brian Di Donato
CFO & Head of Strategy4.2yrsUS$3.35m0.038%
$ 739.6k
Tina Leger
Chief Human Resources Officer2.3yrsUS$1.04m0%
$ 0
David Berman
Head of Research & Development5.4yrsUS$4.40m0%
$ 0
John Trainer
SVP & Chief Operating Officerless than a yearkeine Datenkeine Daten
John Goll
SVP, Finance & Chief Accounting Officerless than a yearkeine Datenkeine Daten
Annelise Vuidepot
CTO and Head of Pipeline & Platform Researchno datakeine Datenkeine Daten
Sean Buckley
VP & Chief Information Officerless than a yearkeine Datenkeine Daten
Clayton Robertson
Head of Investor Relationsno datakeine Datenkeine Daten
Lily Hepworth
General Counsel & Company Secretary3.4yrskeine Datenkeine Daten
Elizabeth Jobes
Chief Compliance Officerless than a yearkeine Datenkeine Daten
Sébastien Desprez
Head of Communications2.4yrskeine Datenkeine Daten

2.4yrs

Durchschnittliche Betriebszugehörigkeit

56yo

Durchschnittliches Alter

Erfahrenes Management: IMCRDas Führungsteam des Unternehmens gilt als erfahren (2.3 Jahre durchschnittliche Betriebszugehörigkeit).


Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Bahija Jallal
CEO & Executive Director5.4yrsUS$11.68mkeine Daten
John Bell
Independent Non-Executive Chairman9.3yrsUS$416.99k0.027%
$ 517.4k
Kristine Peterson
Independent Non-Executive Director6.6yrsUS$389.49k0%
$ 0
Robert Perez
Independent Non-Executive Director4.8yrskeine Datenkeine Daten
Roy Steven Herbst
Independent Non-Executive Director3.4yrsUS$386.99k0%
$ 0
Peter Ratcliffe
Independent Non-Executive Director3.6yrsUS$384.49k0.00067%
$ 12.9k
Ranjeev Krishana
Directorless than a yearkeine Datenkeine Daten
Travis Coy
Independent Non-Executive Director4.8yrskeine Datenkeine Daten
Siddharth Kaul
Independent Non-Executive Director2yrsUS$386.99k0%
$ 0

4.8yrs

Durchschnittliche Betriebszugehörigkeit

63yo

Durchschnittliches Alter

Erfahrener Vorstand: IMCRDie Vorstandsmitglieder gelten als erfahren (4.7 Jahre durchschnittliche Amtszeit).